In the Rabenhorst et al. 2016 cohort, there was a breakpoint with significantly higher PD-L1 in the serum of adult patients with advSM (ASM, SM-AHN, and MCL), compared to non-advanced mastocytosis (ISM and CM). The gene discussed is CD274; the disease is mastocytosis.